Oxfam has hailed the Indian Supreme Court’s ruling against a patent protection petition filed by multinational pharmaceutical company Novartis as a huge victory for public health.
Mohga Kamal-Yanni, Oxfam senior policy adviser, said: “Oxfam is delighted that GAVI has raised more than $4bn to vaccinate children against killer diseases.
